Stock exchange in Frankfurt: Dax remains stable at just under 16,000 points

Stock exchange in Frankfurt: Dax remains stable at just under 16,000 points

The 16,000 points remain the focus of Dax investors. After the rally on Friday, the leading German index remained just below this value at the start of the week, but hardly moved. It was similar on Tuesday.

The 16,000 points remain the focus of Dax investors. After the rally on Friday, the leading German index remained just below this value at the start of the week, but hardly moved. It was similar on Tuesday.

With an increase of 0.09 percent to 15,938.36 points, the leading index hardly got anywhere in early trading. The MDax lost 0.70 percent to 27,349.38 points. The Eurozone leading index EuroStoxx 50 fell by 0.36 percent to 4333.16 points.

For four weeks, the Dax has been in a range of around 400 points or just over two percent. He gets support below 15,700 points, but so far it’s over at 16,000.

On Wednesday, the inflation data from Germany and the USA could possibly see more movement in the market. The impending default by the United States will also remain in sight if Congress does not raise the debt ceiling soon.

On the company side, Daimler Truck with the final quarterly figures and Fresenius with the first key figures were the main focus from the leading index. The commercial vehicle manufacturer Daimler Truck almost tripled its profit in the first quarter. The North American business, however, was probably disappointing. The share lost 3.6 percent at the end of the index.

In contrast, the Fresenius share jumped to the top of the Dax with a plus of 5.0 percent. The hospital operator and medical group had a surprisingly dynamic start to the new year. Sales increased moderately, and although the operating result adjusted for special effects declined, it was still significantly better than analysts had expected.

Vague takeover speculation gave the RWE share a plus of 1.1 percent. At the bottom of the MDax, K+S lost 5.4 percent because the fertilizer manufacturer became more cautious about the current year.

Changes in the composition of the MDax and SDax were also considered. SMA Solar took the place of drug researcher Evotec in the mid-cap index.

Source: Stern

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts